The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab and brentuximab vedotin (BV)-based, response‐adapted treatment in children, adolescents, and young adults (CAYA) with standard-risk relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Primary analysis.
 
Peter D. Cole
No Relationships to Disclose
 
Christine Mauz-Körholz
No Relationships to Disclose
 
Maurizio Mascarin
No Relationships to Disclose
 
Gérard Michel
No Relationships to Disclose
 
Stacy Cooper
No Relationships to Disclose
 
Auke Beishuizen
No Relationships to Disclose
 
Kasey J. Leger
Consulting or Advisory Role - BTG; Jazz Pharmaceuticals
Research Funding - Abbott Laboratories
Travel, Accommodations, Expenses - BTG; Jazz Pharmaceuticals
 
Loredana Amoroso
No Relationships to Disclose
 
Salvatore Buffardi
No Relationships to Disclose
 
Charlotte Rigaud
No Relationships to Disclose
 
Markus Puhlmann
Employment - Merck; Seagen
Leadership - Merck; Seagen
Stock and Other Ownership Interests - Merck; Seagen
Honoraria - Merck; Seagen
 
Stephen Francis
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Mariana Sacchi
No Relationships to Disclose
 
Richard A. Drachtman
Honoraria - ApoPharma; Bristol-Myers Squibb; Global Therapeutics; Novartis
Consulting or Advisory Role - ApoPharma; Bristol-Myers Squibb; Celgene; Global Therapeutics; Novartis
Speakers' Bureau - Global Therapeutics; Novartis
Research Funding - Global Therapeutics (Inst); Novartis (Inst)
 
Paul David Harker-Murray
Speakers' Bureau - Merck (I)
 
Thierry Leblanc
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Stephen Daw
No Relationships to Disclose
 
Kara M. Kelly
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb